Document is current
Any future updates will be listed below
-
Authors
Davie, Alison https://orcid.org/0000-0003-2256-8919
Traoré, Sory
Badreldin, Waleed
Torstensson, Astrid
Cakar, Esra
McCullough, Anuja C.
Tempelaar, Susan
Fenwick, Elisabeth
Hall, Peter S.
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 28 February 2025
First Online: 8 April 2025
Declarations
:
: Alison Davie, Sory Traoré, Waleed Badreldin and Astrid Torstensson are all employees of Eli Lilly and Company. Peter S Hall has disclosed an advisory role with Eli Lilly and Company Ltd.; for which an honorarium was received for consultancy in the development of this study. Esra Cakar and Anuja C. McCullough were employees of OPEN Health HEOR & Market Access at the time that the work was undertaken. Esra Cakar is now an employee of Pfizer. Anuja C. McCullough is now an employee of the National Institute for Health and Care Excellence. Susan Tempelaar and Elisabeth Fenwick are employees of OPEN Health HEOR & Market Access. OPEN Health HEOR & Market Access received funding from Eli Lilly and Company Ltd. for consultancy and study development.
: This study was based on a previously conducted randomized, open-label phase 3 study and does not contain any new data evaluating human participants or animals. Eli Lilly and Company Ltd. approve the use of these data.
